ALPHA TRIBE

Indegene LimitedUpdates, 29-01-2026: Press Release

29-01-2026 | 06:40 pm

Indegene reported strong Q3 FY26: Revenue hit INR 942.1 Cr (+30.8% YoY), Adj. EBITDA reached INR 174.7 Cr (+15.7% YoY). This marks the first $100M+ revenue quarter. Key wins include two $10M+ ACV contracts. Strategic acquisitions of BioPharm and Warn & Co. were completed.

No comments yet. Be the first to comment!

All announcements from Indegene Limited